PatientIQ Raises $30 Million in Series C Funding
PatientIQ, a Chicago-based healthcare technology company, announced it has raised $30 million in a Series C funding round. The round was led by Hughes & Company, with participation from Health Enterprise Partners and August Capital. PatientIQ specializes in helping healthcare professionals collect and utilize patient-reported outcomes to improve the quality of care, drive research initiatives, and enhance overall healthcare delivery.
Leadership and Vision
Matthew Gitelis, CEO and co-founder of PatientIQ, continues to lead the company in its mission to transform healthcare through data-driven insights. "Our focus remains on empowering healthcare providers to make informed decisions that lead to better patient outcomes," said Gitelis.
Strategic Use of Funds
The newly acquired funds are expected to be used to expand PatientIQ's platform capabilities, increase market reach, and potentially grow the team. These strategic moves aim to further PatientIQ's goal of utilizing patient-reported data to improve healthcare outcomes across various medical settings.
Investor Confidence
The participation of Hughes & Company as the lead investor, along with Health Enterprise Partners and August Capital, underscores the confidence in PatientIQ's unique approach to healthcare improvement. By leveraging patient-reported outcomes, PatientIQ is positioned to make a significant impact in the healthcare sector.
With this latest funding round, PatientIQ is set to continue its development and expansion efforts, providing healthcare providers with the necessary tools to enhance patient care and outcomes.